Mission
One person with the power of an entire pharmaceutical company.
ABYA Genomics builds SPECTRE, a scientific superintelligence ecosystem. You set the question. Its agents read the literature and run the analyses, then go round again until the result holds.
Mission
Achieve the scientific singularity.
Tim Szalay started ABYA Genomics in January 2025 to read his own genome and find the mutation behind his arthritis.
SPECTRE applies that work to drug discovery, genomics and personalized medicine. Its agents draw on 400 million articles and protocols and more than 2,000 computational tools, and they keep a project running after you log off.
Vision
Science belongs to everyone who dares.
A lab’s size and budget used to decide which questions got an answer. We think the next century of human health will turn on the questions people ask and the intelligence they can put behind each one.
Milestones